Ask AI
ProCE Banner Activity

Carbapenem-Resistant Acinetobacter baumannii: Applying Best Practices in Complex Clinical Scenarios

Podcast Episodes

Listen to expert faculty share their approach to optimizing antimicrobial therapy in complex clinical cases caused by carbapenem-resistant Acinetobacter baumannii.

Released: November 15, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc.

Faculty Disclosure

Primary Author

Emily Heil, PharmD, MS, BCIDP, AAHIVP

Professor
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, Maryland

Emily Heil, PharmD, MS, BCIDP, AAHIVP, has no relevant financial relationships to disclose.

Trevor Van Schooneveld, MD, FSHEA, FACP, FIDSA

Professor, Division of Infectious Diseases
Medical Director, Antimicrobial Stewardship Program
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Trevor Van Schooneveld, MD, FSHEA, FACPconsultant/advisor/speaker: bioMérieux, Thermo Fisher; researcher: AN2 Therapeutics, Insmed.

Laila Woc-Colburn, MD

Associate Professor
Divsion of Infectious Disesases
Emory University School of Medicine
Emory Healthcare
Atlanta, Georgia

Laila Woc-Colburn, MD, has no relevant financial relationships to disclose.